The prognosis of bulky hepatocellular carcinoma with nonmajor branch portal vein tumor thrombosis

av Jang, Tyng-Yuan, Huang, Ching-I., Yeh, Ming-Lun, Lin, Zu-Yau, Chen, Shinn-Cherng, Chuang, Wan-Long
I publikationen Medicine (Baltimore) (2019)

Feasibility and efficacy of helical tomotherapy in cirrhotic patients with unresectable hepatocellular carcinoma

av Huang, Chun-Ming, Huang, Ming-Yii, Tang, Jen-Yang, Chen, Shinn-Cherng, Wang, Liang-Yen, Lin, Zu-Yau, Huang, Chih-Jen
I publikationen World J Surg Oncol (2015)

Clinical Evaluation of the Automated COBAS AMPLICOR HCV MONITOR Test Version 2.0 for Quantifying Serum Hepatitis C Virus RNA and Comparison to the Quantiplex HCV Version 2.0 Test

av Yu, Ming-Lung, Chuang, Wan-Long, Dai, Chia-Yen, Chen, Shinn-Cherng, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Chang, Wen-Yu
Publicerad 2000

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma

av Yeh, Ming-Lun, Huang, Ching-I, Huang, Chung-Feng, Hsieh, Ming-Yen, Lin, Zu-Yau, Huang, Jee-Fu, Dai, Chia-Yen, Yu, Ming-Lung, Chen, Shinn-Cherng, Chuang, Wan-Long
I publikationen PLoS One (2017)

Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals

av Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Ching-I, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Chen, Jyh-Jou, Yu, Ming-Lung
I publikationen Sci Rep (2018)

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study

av Yu, Ming-Lung, Dai, Chia-Yen, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Tsai, Jung-Fa, Chang, Wen-Yu, Chuang, Wan-Long
Publicerad 2005

Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan

av Yang, Jeng-Fu, Kao, Yi-Hui, Dai, Chia-Yen, Huang, Jee-Fu, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Hsieh, Ming-Yuh, Wang, Liang-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicerad 2010

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients

av Yeh, Ming-Lun, Peng, Cheng-Yuan, Dai, Chia-Yen, Lai, Hsueh-Chou, Huang, Chung-Feng, Hsieh, Ming-Yen, Huang, Jee-Fu, Chen, Shinn-Cherng, Lin, Zu-Yau, Yu, Ming-Lung, Chuang, Wan-Long
I publikationen PLoS One (2015)

Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin

av Dai, Chia-Yen, Chuang, Wan-Long, Chang, Wen-Yu, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Hou, Nei-Jen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Yu, Ming-Lung
I publikationen World J Gastroenterol (2005)

Association of hyperuricemia with disease severity in chronic hepatitis C patients

av Jang, Tyng-Yuan, Yeh, Ming-Lun, Huang, Ching-I, Lin, Zu-Yau, Chen, Shinn-Cherng, Hsieh, Meng-Hsuan, Dai, Chia-Yen, Huang, Jee-Fu, Huang, Chung-Feng, Chuang, Wan-Long, Yu, Ming-Lung
I publikationen PLoS One (2018)

The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C

av Batsaikhan, Batbold, Huang, Ching-I, Yeh, Ming-Lun, Huang, Chung-Feng, Hou, Nei-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Yu, Ming-Lung, Chuang, Wan-Long, Lee, Jin-Ching, Dai, Chia-Yen
I publikationen Oncotarget (2018)

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

av Yu, Ming‐Lung, Dai, Chia‐Yen, Huang, Jee‐Fu, Hou, Nai‐Jen, Lee, Li‐Po, Hsieh, Ming‐Yen, Chiu, Chang‐Fu, Lin, Zu‐Yau, Chen, Shinn‐Cherng, Hsieh, Ming‐Yuh, Wang, Liang‐Yen, Chang, Wen‐Yu
Publicerad 2007

Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy

av Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Cing-Yi, Tsai, Pei-Chien, Ko, Yu-Min, Chen, Kuan-Yu, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Chuang, Wan-Long, Huang, Jee-Fu, Yu, Ming-Lung
I publikationen Medicine (Baltimore) (2016)

Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection

av Huang, Chung-Feng, Wang, Shu-Chi, Chang, Wen-Tsan, Yeh, Ming-Lun, Huang, Ching-I, Lin, Zu-Yau, Chen, Shinn-Cherng, Chuang, Wan-Long, Huang, Jee-Fu, Dai, Chia-Yen, Chen, Yao-Li, Yu, Ming-Lung
I publikationen Sci Rep (2018)

Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin

av Yu, Ming-Lung, Liu, Chen-Hua, Huang, Chung-Feng, Tseng, Tai-Chung, Huang, Jee-Fu, Dai, Chia-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Kao, Jia-Horng
Publicerad 2012

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients

av Huang, Chung-Feng, Chen, Jyh-Jou, Yeh, Ming-Lun, Huang, Ching-I, Hsieh, Ming-Yen, Yang, Hua-Ling, Dai, Chia-Yen, Huang, Jee-Fu, Lin, Zu-Yau, Chen, Shinn-Cherng, Chuang, Wan-Long, Chen, Yao-Li, Yu, Ming-Lung
I publikationen Sci Rep (2015)

Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C

av Yeh, Ming-Lun, Huang, Ching-I, Huang, Chung-Feng, Hsieh, Meng-Hsuan, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Kuo, Po-Lin, Kuo, Hsing-Tao, Dai, Chia-Yen, Yu, Ming-Lung, Chuang, Wan-Long
I publikationen Oncotarget (2018)

Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study

av Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Ching-I, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Wei, Yu-Ju, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
I publikationen BMJ Open (2019)

Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients

av Huang, Chung-Feng, Dai, Chia-Yen, Yeh, Ming-Lun, Huang, Jee-Fu, Huang, Ching-I, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Lin, Yi-Ching, Yu, Ming-Lung
Publicerad 2013

HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma

av Lin, Shi-Ming, Lu, Sheng-Nan, Chen, Ping-Tsung, Jeng, Long-Bin, Chen, Shinn-Cherng, Hu, Chi-Tan, Yang, Sien-Sing, Le Berre, Marie-Aude, Liu, Xuan, Mitchell, David Y., Prins, Klaas, Grevel, Joachim, Peña, Carol A. E., Meinhardt, Gerold
I publikationen Hepatol Int (2016)